BioRestorative Therapies, Inc. (OTCMKTS:BRTX – Get Free Report) shares passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $1.96 and traded as low as $1.55. BioRestorative Therapies shares last traded at $1.62, with a volume of 13,195 shares traded.
BioRestorative Therapies Price Performance
The firm has a 50-day moving average of $1.96 and a 200 day moving average of $1.71. The stock has a market capitalization of $11.21 million, a price-to-earnings ratio of -1.06 and a beta of 64.37.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc engages in the development of therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders, including obesity and diabetes. The company’s initial investigational therapeutic product being called BRTX-100 focuses on treating damage by an autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process.
Featured Stories
- Five stocks we like better than BioRestorative Therapies
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- 3 Undervalued Stocks You Can Buy at a Discount Now
- Pros And Cons Of Monthly Dividend Stocks
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- How to buy stock: A step-by-step guide for beginnersÂ
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
